Aerosolized iloprost therapy could not replace long-term IV epoprostenol (prostacyclin) administration in severe pulmonary hypertension.


OBJECTIVES To switch patients with severe pulmonary hypertension and previous life-threatening catheter-related complications from long-term IV epoprostenol therapy to aerosolized iloprost therapy. DESIGN Open, uncontrolled trial. SETTING Medical ICU of a university hospital. PATIENTS Two patients with primary pulmonary hypertension and one patient… (More)


2 Figures and Tables

Slides referencing similar topics